CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 110 filers reported holding CUREVAC N V in Q4 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,772 | -41.4% | 3,187,699 | -10.6% | 0.00% | -40.0% |
| Q2 2023 | $37,138 | +39.7% | 3,564,026 | -6.6% | 0.01% | +25.0% |
| Q1 2023 | $26,583 | +695.9% | 3,813,896 | +588.6% | 0.00% | +300.0% |
| Q4 2022 | $3,340 | -100.0% | 553,865 | +22.9% | 0.00% | 0.0% |
| Q1 2022 | $8,837,000 | -48.9% | 450,642 | -10.6% | 0.00% | -50.0% |
| Q4 2021 | $17,297,000 | -34.5% | 504,148 | +4.3% | 0.00% | 0.0% |
| Q3 2021 | $26,402,000 | +11582.3% | 483,371 | +15624.5% | 0.00% | – |
| Q2 2021 | $226,000 | -99.8% | 3,074 | -99.8% | 0.00% | -100.0% |
| Q1 2021 | $125,308,000 | +21.9% | 1,370,088 | +8.1% | 0.01% | +18.2% |
| Q4 2020 | $102,780,000 | +83.6% | 1,267,798 | +5.4% | 0.01% | +83.3% |
| Q3 2020 | $55,973,000 | – | 1,202,421 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $16,942,326 | 13.48% |
| RA Capital Management | 12,245,955 | $127,602,851 | 2.41% |
| Avidity Partners Management LP | 4,300,000 | $44,806,000 | 1.56% |
| Camber Capital Management LP | 1,462,500 | $15,239 | 0.50% |
| Eversept Partners, LP | 357,342 | $3,723,504 | 0.31% |
| Ghisallo Capital Management LLC | 100,000 | $1,042,000 | 0.12% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 226,134 | $2,356,316 | 0.08% |
| Green Alpha Advisors, LLC | 11,492 | $119,747 | 0.08% |
| Alyeska Investment Group, L.P. | 899,423 | $9,371,988 | 0.07% |
| Virtus ETF Advisers LLC | 10,692 | $111,411 | 0.07% |